Immunome VP Finance/PAO Bob Lapetina resigns; Max Rosett named PAO effective May 10

Immunome Inc.

Bob Lapetina resigned as VP Finance, Corporate Controller and principal accounting officer effective May 10, 2024; departure not due to disagreement.
Max Rosett appointed principal accounting officer effective May 10, 2024; he currently serves as Interim CFO, EVP Operations since December 2023.
Rosett previously held roles at Morphimmune and Research Bridge Partners; no new material plan or contract entered in connection with appointment.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Max Rosett

principal accounting officer

IMNM · Immunome Inc.

Effective: 2024-05-10
Filed: April 30, 2024, 7:59 PM ET

the Company’s board of directors appointed Max Rosett, in addition to his other titles, as the Company’s principal accounting officer effective immediately upon the effectiveness of Mr. Lapetina’s resignation.

Departed

Bob Lapetina

Vice President, Finance, Corporate Controller, and principal accounting officer

IMNM · Immunome Inc.

Effective: 2024-05-10
Successor: Max Rosett
Filed: April 30, 2024, 7:59 PM ET

Bob Lapetina notified Immunome, Inc. (the “Company”) that he will be resigning from his positions as the Company’s Vice President, Finance, Corporate Controller, and principal accounting officer to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Max Rosett was appointed as principal accounting officer at Immunome Inc..

Action: appointed
Role: principal accounting officer

Exact text from the filing

the Company’s board of directors appointed Max Rosett, in addition to his other titles, as the Company’s principal accounting officer effective immediately upon the effectiveness of Mr. Lapetina’s resignation.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Bob Lapetina departed as Vice President, Finance, Corporate Controller, and principal accounting officer at Immunome Inc..

Action: resigning
Role: Vice President, Finance, Corporate Controller, and principal accounting officer

Exact text from the filing

Bob Lapetina notified Immunome, Inc. (the “Company”) that he will be resigning from his positions as the Company’s Vice President, Finance, Corporate Controller, and principal accounting officer to pursue other opportunities.

View on SEC.gov

Immunome Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-054910

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.